Arcturus Therapeutics Holdings Inc (ARCT)
Stock-Based Compensation
$21.10M
TTM · Period ending: · USD
ARCT Stock-Based Compensation
Latest reported$21.10Mperiod ending
Latest reported$21.10Mperiod ending
ARCT TTM Stock-Based Comp ($1.54M → $21.10M)
TTM stock-based compensation
High-resolution chart · PNG
ARCT stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 21,102,000 | |
| 23,071,000 | |
| 25,408,000 | |
| 27,574,000 | |
| 31,338,000 | |
| 34,562,000 | |
| 37,988,000 | |
| 37,820,000 | |
| 37,596,000 | |
| 36,555,000 | |
| 34,649,000 | |
| 32,364,000 | |
| 32,531,000 | |
| 31,422,000 | |
| 30,611,000 | |
| 31,599,000 | |
| 29,033,000 | |
| 29,299,000 | |
| 28,915,000 | |
| 24,223,000 | |
| 19,341,000 | |
| 12,902,000 | |
| 6,764,000 | |
| 4,735,000 | |
| 3,130,000 | |
| 2,432,000 | |
| 1,982,000 | |
| 1,691,000 | |
| 1,895,000 | |
| 1,632,000 | |
| 1,259,000 | |
| 2,099,000 | |
| 1,662,000 | |
| 1,677,000 | |
| 2,170,000 | |
| 1,365,000 | |
| 1,860,000 | |
| 2,283,000 | |
| 2,500,000 | |
| 2,538,000 | |
| 2,478,000 | |
| 2,318,000 | |
| 2,365,000 | |
| 2,573,000 | |
| 3,014,000 | |
| 3,537,000 | |
| 4,089,000 | |
| 3,807,000 | |
| 3,073,000 | |
| 2,871,000 | |
| 1,541,000 | |
| 1,040,000 | |
| 754,000 | |
| 22,000 |